Skip to content

Relationship between neoadjuvant therapy and perioperative and long-term treatment efficacy in patients with gastric cancer: a single-center prospective cohort study

Relationship between neoadjuvant therapy and perioperative and long-term treatment efficacy in patients with gastric cancer: a single-center prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096321
Enrollment
Unknown
Registered
2025-01-21
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Neoadjuvant therapy + radical surgery:None
Radical surgery:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients aged 18-75 years with advanced gastric cancer; Neoadjuvant therapy (chemotherapy, chemotherapy + immunotherapy, chemotherapy + radiotherapy) is required; The patient voluntarily and agrees to participate in the clinical study;

Exclusion criteria

Exclusion criteria: Gastric cancer complicated with invasion and metastasis; Gastric cancer with other malignancies; Gastric cancer with other organ dysfunction; Reluctant to participate in clinical studies.

Design outcomes

Primary

MeasureTime frame
Infection complication;Postoperative hemorrhage;Anastomotic fistula;Delayed gastric emptying;First exhaust time;Time of first feeding after surgery;Length of stay;Postoperative pain score;Blood routine examination;Biochemical examination;Inflammatory index;Relapse-free survival;Overall survival rate;Postoperative pathological complete remission;Response to neoadjuvant therapy;

Countries

China

Contacts

Public ContactWang Yong

West China Hospital, Sichuan University

wy642192587@163.com+86 134 0866 4825

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026